Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OTLK | AZN | AMGN | GILD | BMY |
| Company | Outlook Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.4200 | 165.35 | 365.08 | 130.51 | 60.08 |
| High | 1.4550 | 169.43 | 368.91 | 132.87 | 61.02 |
| Low | 1.3800 | 164.82 | 362.14 | 129.13 | 59.80 |
| Latest | 1.4200 | 169.34 | 366.24 | 130.28 | 60.93 |
| Change | +0.0400 | +4.82 | +2.07 | -2.93 | +0.77 |
| % Change | +2.90% | +2.93% | +0.57% | -2.20% | +1.28% |
| Volume | 4,145,200 | 1,986,300 | 2,881,900 | 8,371,101 | 7,744,500 |
| 20-Day Average Volume | 8,648,885 | 2,732,260 | 2,290,900 | 7,718,900 | 12,082,345 |
| Previous Close | 1.3800 | 164.52 | 364.17 | 133.21 | 60.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.5605 | 179.74 | 361.98 | 130.28 | 57.96 |
| 20-Day Raw Stochastic | 21.05% | 16.32% | 62.78% | 39.02% | 81.90% |
| 20-Day Relative Strength | 54.84 | 42.39 | 56.74 | 49.52 | 58.32 |
| Weighted Alpha | +40.01 | +5.72 | +20.38 | +8.88 | +27.27 |
| Today's Opinion | 72% Buy | 88% Sell | 72% Buy | 32% Sell | 56% Buy |
| Previous Opinion | 72% Buy | 88% Sell | 72% Buy | 8% Sell | 56% Buy |
| Last Month's Opinion | 56% Buy | 72% Sell | 8% Sell | 72% Sell | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -17.92% since 07/14/26 | +2.94% since 07/14/26 | +3.09% since 07/14/26 | +0.18% since 07/14/26 | +6.99% since 07/14/26 |
| Low | 1.3200 on 07/17/26 | 164.06 on 07/20/26 | 353.95 on 07/15/26 | 129.13 on 07/21/26 | 57.04 on 07/15/26 |
| High | 1.7650 on 07/15/26 | 170.37 on 07/16/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 1-Month | |||||
| %Chg | -10.13% since 06/18/26 | -3.20% since 06/18/26 | +8.48% since 06/18/26 | +5.27% since 06/18/26 | +12.83% since 06/18/26 |
| Low | 1.3000 on 07/06/26 | 164.06 on 07/20/26 | 337.60 on 06/22/26 | 123.00 on 06/22/26 | 53.99 on 06/22/26 |
| High | 1.8800 on 06/22/26 | 196.41 on 07/02/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 3-Month | |||||
| %Chg | +344.58% since 04/21/26 | -13.50% since 04/21/26 | +6.20% since 04/21/26 | -2.26% since 04/21/26 | +2.59% since 04/21/26 |
| Low | 0.2066 on 05/07/26 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 1.8800 on 06/22/26 | 196.65 on 04/22/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 6-Month | |||||
| %Chg | +180.63% since 01/21/26 | -6.48% since 01/21/26 | +6.59% since 01/21/26 | +0.91% since 01/21/26 | +11.80% since 01/21/26 |
| Low | 0.1611 on 03/24/26 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 1.8800 on 06/22/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 205,050 | 255,155,376 | 196,545,472 | 165,389,536 | 122,850,992 |
| Shares Outstanding, K | 148,587 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 1,410,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -62,420,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 130,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -4,450,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 0.77 | 0.24 | 0.41 | 0.32 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 05/15/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 08/13/26 | 07/27/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.24 | 16.57 | 16.04 | 10.24 |